Barry M. Deutsch
Director of Finance/CFO at Aerami Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anne Michelle Whitaker | F | 56 |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 6 years |
| John Stuart Patton | M | 77 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 15 years |
| Steven T. Thornton | M | 67 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 7 years |
| Joshua Ziel | M | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 2 years |
| Darlene Deptula-Hicks | F | 66 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 3 years |
| Adam Stern | M | 60 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 10 years |
| Bill Welch | M | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | - |
| Mei-Chang Kuo | M | 75 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 14 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gail Fosler | F | 76 | 4 years | |
| Albert P. L. Stroucken | M | 76 | 4 years | |
| Kongkiat Opaswongkarn | M | 67 |
The Wharton School of the University of Pennsylvania
| 6 years |
| Ludwig Hantson | M | 61 | 1 years | |
| Robert Hombach | M | 58 | 1 years | |
| Beth Hecht | F | 60 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Amy Pott | F | 47 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 12 years |
| Scott Applebaum | M | 57 | 2 years | |
| Marla Persky | F | 68 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Donna M. Walsh | F | - |
The Wharton School of the University of Pennsylvania
| 14 years |
| Sotirios G. Stergiopoulos | M | 52 | - | |
| Dawn Halkuff | F | 53 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Eric Schwartz | M | 61 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Richard Philip Furst | M | 60 |
Kellogg School of Management
The Wharton School of the University of Pennsylvania
| 7 years |
| John Schmid | M | 61 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 4 years |
| Scott Pinkus | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Christoph Brackmann | M | - | - | |
| Karen Ferrante | M | 66 | 1 years | |
| Scott W. Meacham | M | 64 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 8 years |
| Lee Jeffrey Tawil | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Gregg David Pollack | M | 62 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Andrea Hunt | F | 64 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 29 years |
| Matthew David Ginsburg | M | 60 |
Kellogg School of Management
| 3 years |
| Barbara-Jean Bormann-Kennedy | M | 65 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Stephanie Dorn Miller | F | 50 | 1 years | |
| Allison Wey | F | - |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Bill Gantz | M | 86 |
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | - |
| Mark Thierer | M | 64 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 1 years |
| Blake E. Devitt | M | 77 | 1 years | |
| Jonathan Rigby | M | 56 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Francois Nader | M | 67 | 1 years | |
| Sanjiv Sobti | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jacques Suzanne | F | 53 | 4 years | |
| Robert Davis | M | 57 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 6 years |
| Glenn Fuhrman | M | 58 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Patrick Enright | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Sean Nolan | M | 56 |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | 5 years |
| John D. Forsyth | M | 76 | 1 years | |
| Jeffrey Whitnell | M | 68 |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | 2 years |
| Marc A. Utay | M | 64 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeffrey Sherman | M | 69 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Jacob Wallenberg | M | 68 |
The Wharton School of the University of Pennsylvania
| 5 years |
| James R. Gavin | M | 78 | 1 years | |
| Lisa Yañez | F | - |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | 1 years |
| Ian Clark | M | 62 | 2 years | |
| Judy Krandel | F | 59 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Richard Diamond | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Andrew Clark | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Richard Baum | M | 63 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Frank Lee | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeffrey Sloan | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Nicholas Parry Jones | M | 65 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jon Erickson | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Mindy M. Posoff | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Gail Hoffman | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jim Manzi | M | - |
The Wharton School of the University of Pennsylvania
| 1 years |
| Warren Bingham | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
| Edwin R Kraft | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Kiran Sidhu | M | 59 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jia He | M | 70 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Gary Lauder | M | 61 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Daniel F. Summa | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Joe E. Parzick | M | 69 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Christian Felipe | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| James Earl | M | 67 |
The Wharton School of the University of Pennsylvania
| 2 years |
| John Popp | M | 68 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Hau Leung Lee | M | 71 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Mark First | M | 59 |
The Wharton School of the University of Pennsylvania
| 4 years |
| David Matlin | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andrew Lazar | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Richard Mashaal | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Rob Stavis | M | 61 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Parag Phoolchand Saxena | M | 69 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Steve Lipper | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Marc David Stern | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| David Oppenheimer | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Timothy P. McCann | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| John Martin | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Alan Menkes | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Darius Lilaoonwala | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Michael S. Castleman | M | 56 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Craig Benedict Steinberg | M | 63 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Alan Geoffrey Mnuchin | M | 64 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Marco Diego de Benedetti | M | 61 |
The Wharton School of the University of Pennsylvania
| 2 years |
| John Flannery | M | 63 |
The Wharton School of the University of Pennsylvania
| 2 years |
| David Joseph Gilbert | M | 66 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Eric Kenneth Seiff | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
| James R. Agley | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Mirzan bin Mahathir | M | 66 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Christopher Dewey | M | 80 |
The Wharton School of the University of Pennsylvania
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 95 | 96.94% |
| Ireland | 8 | 8.16% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry M. Deutsch
- Personal Network